RoweMed
RoweMed AG is a German medical device manufacturer that designs and produces certified plastic disposables and custom systems for infusion, injection, and transfusion applications, serving MedTech, pharmaceutical, and biotechnology customers from its Parchim cleanroom facilities.
- Company typePrivate
- Founded2000
- HeadquartersParchim, Germany
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What RoweMed does
RoweMed AG – Medical 4 Life is a German medical device manufacturer founded in 2000 and headquartered in Parchim, specializing in plastic systems for infusion, injection, and transfusion applications. The company develops and produces both CE-certified catalog disposables (RowePhil, RoweSpike, RoweFil, RowePaed, RoweEpiflow, RoweBagSpike, RowePhob, spiral lines and transfer sets) and customer-specific special products for medical technology, pharmaceutical, and biotechnology customers. Manufacturing is conducted under MDR 2017/745 and EN ISO 13485:2016 quality systems in four ISO 7 clean rooms using injection molding, blow molding, solvent and UV bonding, ultrasonic and thermal welding, and validated EtO, gamma, and autoclave sterilization.
The business model is B2B direct sales into enterprise customers, with turnkey project execution spanning CAD design, rapid prototyping, material selection, cleanroom production, and full regulatory documentation. Production volumes scale from 200-unit small series to 3 million units per year, and the company lists more than 300 articles carrying its own regulatory approvals on the international market. Distribution is direct, supported by participation in EANM, Medica, and Compamed trade shows and an active LinkedIn and corporate web presence.
RoweMed has positioned itself for advanced therapy applications through the MediFlow joint research project with the Institute for Implant Technology and Biomaterials (IIB, since 2023) and the NEXCELL future research association (since 2025) with Miltenyi Biotec, the University of Rostock, and Rostock University Medical Center, both backed by ERDF funding. The company is privately held as an Aktiengesellschaft, led by CEO Dr. Dirk Forberger and board member Frank Dietrich, with a supervisory board chaired by Dr. Karl J. Werner, and reports approximately 170 employees as of August 2023.
RoweMed firmographics
Firmographics- Name
- RoweMed
- Legal name
- RoweMed AG – Medical 4 Life
- Website
- https://rowemed.de
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- RoweMed AG is a German medical device manufacturer that designs and produces certified plastic disposables and custom systems for infusion, injection, and transfusion applications, serving MedTech, pharmaceutical, and biotechnology customers from its Parchim cleanroom facilities.
- Ownership category
- akta.pro rank
RoweMed industry classification
Industry- Product category
- Medical Plastic Components Manufacturing
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies) (HLAGAGAH)
Keywords
Where RoweMed is headquartered
LocationHeadquarters
- HQ city
- Parchim
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
RoweMed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Medical Plastic Products Manufacturing: Manufacture and sale of medical plastic components and systems, including catalog products (CE-certified standard products for infusion, injection, and transfusion technology) and custom special products developed for specific customer requirements. Production volumes range from small series (200 units) to high-volume automated production (up to 3 million units per year).
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
RoweMed product offering
Product offeringCore offering
RoweMed AG develops and manufactures single-use medical plastic components and systems for infusion, injection, and transfusion techniques. The portfolio combines CE-certified catalog products (e.g., RowePhil, RoweFil, RoweSpike, RoweEpiflow, RowePaed, RoweBagSpike, RowePhob) with custom-developed components and turnkey services covering CAD design, rapid prototyping, cleanroom injection molding (ISO 8), assembly and packaging (ISO 7), sterilization, and full regulatory documentation per EU MDR 2017/745. Production volumes scale from 200-unit small series to 3 million units per year for international MedTech, pharmaceutical, and biotechnology customers.
Product overview
RoweMed AG – Medical 4 Life is an innovative medical technology company specializing in medical plastic solutions. The offering consists of catalog products (CE-certified single-use disposables for infusion, injection, and transfusion technique) and custom/special products (customer-specific plastic components and systems for MedTech, Pharma, and Biotech). The catalog portfolio includes the RowePhil line (infusion sets in various sizes: 18, 25, 3/18), RoweFil (infusion filters), RoweSpike variants (I, II, II MK/Micro, VI SnapFit), RoweSpiralLines/RoweTransfer-Sets, RoweEpiflow (epidural), RowePaed (pediatric) products, RoweBagSpike, and RowePhob 18/25. The company also offers comprehensive services including product development (from sketch to certified serial production with CAD, prototyping, and testing), cleanroom manufacturing (ISO 8 injection molding, ISO 7 assembly/packaging, sterilization via EtO/gamma/autoclave), and regulatory affairs (MDR/FDA documentation and certification support). The MediFlow joint research project with IIB Warnemünde is developing novel filtration systems for cell and gene therapy.
Differentiator
Problem solved
Functional benefit
Brands
- RowePhil: Product line including RowePhil 18, RowePhil 25, RowePhil 3/18 for liquid management applications
- RoweSpike
- RoweFil
- RoweBagSpike
- RowePhob
- RoweEpiflow
- RowePaed
- RoweInfuset
- RoweSpiralLines
- RoweTransfer-Sets
Products and services
- RowePhil 18 Disposable CE-certified medical plastic component within the RowePhil product line, used as an infusion accessory in infusion, injection, and transfusion technique applications.
- RowePhil 25 Disposable CE-certified medical plastic component within the RowePhil product line, designed for handling fluids in infusion, injection, and transfusion technique applications.
- RowePhil 3/18 Disposable CE-certified medical plastic component in the RowePhil product line for fluid handling in infusion, injection, and transfusion applications.
- RoweFil Disposable CE-certified infusion filter for medical fluid handling applications, part of the standard catalog for infusion, injection, and transfusion technique.
- RoweSpike I Sampling spike product for safe handling and transfer of medical fluids in infusion, injection, and transfusion applications.
- RoweSpike II Sampling spike product for safe handling and transfer of medical fluids in infusion, injection, and transfusion applications.
- RoweSpike II MK/Micro Micro sampling spike variant for safe handling and transfer of medical fluids in infusion, injection, and transfusion applications.
- RoweSpike VI SnapFit SnapFit variant sampling spike for safe handling and transfer of medical fluids, with snap-fit connection technology.
- RoweSpiralLines / RoweTransfer-Sets Spiral lines and transfer sets for medical fluid management in infusion, injection, and transfusion applications.
- RoweEpiflow Medical device for epidural fluid handling applications in anesthesia procedures.
- RowePaed Pediatric-specific medical device for infusion and fluid handling applications designed for use in pediatric care.
- RoweInfuset with RowePaed M Complete pediatric infusion set system incorporating the RowePaed M component for pediatric fluid administration.
- RowePaed M Pediatric-specific fluid administration component for use in infusion systems.
- RoweBagSpike IV bag spike device for safe connection and fluid transfer from infusion bags in medical applications.
- RowePhob 18/25 Medical plastic component with specific 18/25 connector sizing for fluid handling in infusion applications.
- Custom / Special Products (Spezialprodukte) Custom-designed plastic components and systems for MedTech, Pharma, and Biotech applications, including individual development, construction, and manufacturing from single units to large series with optimal technology selection per product.
- Product Development Services Complete product development from initial sketch to market-ready serial product, including CAD design, rapid prototyping, material selection, and product testing; delivered as turnkey projects with full technical documentation per MDR (EU) 2017/745.
- Cleanroom Manufacturing Services Cleanroom production services including injection molding (ISO 8), assembly and packaging (ISO 7), and sterilization (EtO, gamma radiation, autoclave), offered for single units, small series, and automated large-scale production.
- Regulatory Affairs Services Complete technical documentation and regulatory support for medical device approval, including MDR, FDA, and GMP-compliant production documentation, quality assurance, CE and FDA certification support, and validated processes.
Quantifiable outcome
- More than 300 products with own regulatory approval in the market
- +2 more outcomes
Companies that use RoweMed
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
RoweMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
RoweMed partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- NEXCELL Future Research Association (Miltenyi Biotec, University of Rostock, Rostock University Medical Center)coreConsortium developing a highly automated and comprehensively digitized cell and gene therapy platform. RoweMed participates alongside Miltenyi Biotec (project leader), University of Rostock, and Rostock University Medical Center. Total funding of approximately €13 million over four years from ERDF.
- Institute for Implant Technology and Biomaterials (IIB)coreTen-year collaboration with IIB in Warnemünde culminating in the 'MediFlow' joint research project to develop an innovative modular filtration and reservoir system for cell and gene therapy applications. RoweMed and IIB jointly develop the prototype of a novel filter system to be manufactured in Parchim.
- VDMA (Mechanical Engineering Industry Association)minorMembership in the German Mechanical Engineering Industry Association for industry networking and representation.
- BioConValleyminorMembership in the regional biotechnology network for Mecklenburg-Vorpommern.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
RoweMed competitors and assessment
Company assessmentDirect peers
- Terumo Corporation: Japanese global medical device company with a substantial Infusion Systems business (IV catheters, infusion sets, transfusion products) and growing cell and gene therapy manufacturing footprint. Direct competitor in infusion/transfusion disposables and adjacent in C> — both areas of RoweMed's strategic focus.
- Sarstedt AG & Co. KG: German manufacturer of medical devices and laboratory consumables using polymer injection molding, including sample collection systems and infusion accessories. Comparable in cleanroom plastics manufacturing, customer base overlap (Medtech/lab OEMs), and German Mittelstand operating profile.
- ICU Medical, Inc. US-listed pure-play in IV consumables and medical connectors, including IV sets, needle-free connectors, and infusion accessories. Closely comparable product architecture (single-use plastic components for infusion therapy) and similar regulatory-driven B2B sales model to medical device OEMs and hospitals.
- Raumedic AG: German polymer-based medical device and component manufacturer offering customized plastic tubing, catheters, and fluid handling systems for Medtech, Pharma, and Biotech customers. Strongly comparable to RoweMed in product mix (medical-grade plastics, single-use disposables) and B2B sales motion to device OEMs.
- Fresenius Kabi: Global infusion, transfusion, and clinical nutrition medical device business with a large portfolio of IV sets, infusion filters, and single-use disposables. Direct overlap with RoweMed's catalog infusion/transfusion offering and similar regulatory-intensive end markets (hospitals, oncology, critical care).
- B. Braun Melsungen AG: Headquartered in Melsungen — the very city where RoweMed was originally founded in 2000 — B. Braun is a leading German manufacturer of infusion, injection, and transfusion medical devices. Its Hospital Care division directly overlaps RoweMed's core catalog of single-use infusion components, fluid handling systems, and CE-marked disposables, making it the closest large direct peer.
- Vygon Group: French family-owned medical device specialist in single-use vascular access and infusion products for neonatal, pediatric, and adult care. Comparable custom-and-catalog single-use disposables business with similar pediatric/neonatal product niches (e.g., RowePaed/RowePaed M) and direct European B2B sales motion.
Broad incumbents
- Becton, Dickinson and Company (BD): Large-cap US medical technology incumbent with major Medical and Pharmaceutical Systems segments covering infusion disposables, pre-filled systems, and drug delivery. Significant product overlap with RoweMed's infusion/transfusion catalog but vastly broader portfolio and global footprint; serves as the dominant incumbent RoweMed competes against on large OEM contracts.
- Cytiva (Danaher): Global bioprocessing supplier (formerly GE Healthcare Life Sciences) of single-use systems, filtration, and fluid handling for biopharma and cell/gene therapy manufacturing. Overlaps with RoweMed's MediFlow direction (single-use filtration for personalized C>) but at much larger scale and as part of a broader Danaher portfolio.
- Sartorius AG: German bioprocessing incumbent with leading positions in single-use systems for biologics and cell/gene therapy manufacturing. Relevant comparator for RoweMed's strategic push into C> filtration and single-use assemblies, particularly as a partner/competitor for platform-level deals with cell therapy developers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
RoweMed social profiles
Digital presenceRoweMed compliance and trust
Trust signalCompliance3 records
RoweMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
RoweMed leadership team
Management profileNumber of profiles
Profiles6 records
RoweMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RoweMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RoweMed
What does RoweMed do?
RoweMed AG develops and manufactures single-use medical plastic components and systems for infusion, injection, and transfusion techniques. The portfolio combines CE-certified catalog products (e.g., RowePhil, RoweFil, RoweSpike, RoweEpiflow, RowePaed, RoweBagSpike, RowePhob) with custom-developed components and turnkey services covering CAD design, rapid prototyping, cleanroom injection molding (ISO 8), assembly and packaging (ISO 7), sterilization, and full regulatory documentation per EU MDR 2017/745. Production volumes scale from 200-unit small series to 3 million units per year for international MedTech, pharmaceutical, and biotechnology customers.
Is RoweMed a public or private company?
RoweMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RoweMed founded?
RoweMed was founded in 2000. It employs 101 to 250 people.
Where is RoweMed based?
RoweMed is headquartered in Parchim, Germany, in the Europe region.
How does RoweMed make money?
One revenue line is on record: medical Plastic Products Manufacturing.
Who are RoweMed's main competitors?
Direct peers on record are Terumo Corporation, Sarstedt AG & Co. KG, ICU Medical, Inc., Raumedic AG, Fresenius Kabi, B. Braun Melsungen AG and Vygon Group. Broad incumbents are Becton, Dickinson and Company (BD), Cytiva (Danaher) and Sartorius AG.
Does RoweMed have an API?
No public API is recorded for RoweMed.
What industry is RoweMed in?
RoweMed's product category is Medical Plastic Components Manufacturing. Its primary akta.pro industry code is HLAGAGAH, Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies). Its NAICS code is 339113 and its SIC code is 3841.